Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4294621
Max Phase: Preclinical
Molecular Formula: C41H67N15O16
Molecular Weight: 1026.08
Molecule Type: Small molecule
Associated Items:
ID: ALA4294621
Max Phase: Preclinical
Molecular Formula: C41H67N15O16
Molecular Weight: 1026.08
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)NC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(N)=O
Standard InChI: InChI=1S/C41H67N15O16/c1-18(2)29(54-33(65)19(42)5-3-12-47-40(45)46)38(70)55-13-4-6-24(55)37(69)52-23(17-58)36(68)50-21(34(66)49-20(7-9-26(43)59)35(67)51-22(16-57)32(44)64)8-10-27(60)48-15-25-30(62)31(63)39(72-25)56-14-11-28(61)53-41(56)71/h11,14,18-25,29-31,39,57-58,62-63H,3-10,12-13,15-17,42H2,1-2H3,(H2,43,59)(H2,44,64)(H,48,60)(H,49,66)(H,50,68)(H,51,67)(H,52,69)(H,54,65)(H4,45,46,47)(H,53,61,71)/t19-,20-,21-,22-,23-,24-,25+,29-,30+,31+,39+/m0/s1
Standard InChI Key: BMKRCGHWMNVMMY-JLRFQVJRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1026.08 | Molecular Weight (Monoisotopic): 1025.4890 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.. (2018) Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids., 9 (5): [PMID:30108977] [10.1039/C8MD00115D] |
Source(1):